Outcomes of a single centre registry of patients with ischaemic heart disease, qualified for an RF ablation of ventricular arrhythmia after ICD intervention

Kardiologia Polska

Volumn 67, Issue 2, 2009, Pages 123-127

  Szumowski, Łukasz ^a   Przybylski, Andrzej ^a   Maciag, Aleksander ^a   Derejko, Paweł ^a   Bodalski, Robert ^a   Zakrzewska, Joanna ^a   Orczykowski, Michal ^a   Szufladowicz, Ewa ^a   Szwed, Hanna ^a   Walczak, Franciszek ^a  

^a INSTITUTE OF CARDIOLOGY   (Poland)

Author keywords

Implantable cardioverter defibrillator; Radiofrequency ablation; Ventricular tachycardia

Indexed keywords

ACETYLSALICYLIC ACID; ALDOSTERONE ANTAGONIST; AMIODARONE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; SOTALOL;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DEFIBRILLATION; DEFIBRILLATOR; FEMALE; FOLLOW UP; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HOSPITAL DISCHARGE; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; RADIOFREQUENCY ABLATION; RANDOMIZED CONTROLLED TRIAL; REGISTER; THROMBUS;

EID: 64649104166     PISSN: 00229032     EISSN: 00229032     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. The AVID Investigators. Causes of death in the Antiarrhythmics Versus Implantable Defibrillators (AVID) trial. J Am Coll Cardiol 1999; 34: 1552-9.
2. Dorian P, Borggrefe M, Al-Khalidi HR, et al. SHock Inhibition Evaluation with azimiLiDe (SHIELD) Investigators. Placebo-controlled, randomized clinical trial of azimilide for prevention of ventricular tachyarrhythmias in patients with an implantable cardioverter defibrillator. Circulation 2004; 110: 3646-54.
3. Connolly SJ, Dorian P, Roberts RS, et al. Comparison of beta-blockers, amiodarone plus beta-blockers, or sotalol for prevention of shocks from implantable cardioverter defibrillators: the OPTIC Study: a randomized trial. JAMA 2006; 295: 165-71.
4. Maryniak A, Szumowski L, Orczykowski M, et al. Anxiety and depression among the patients with frequent implantable cardioverter-defibrillator discharges. Int J Cardiol 2007 Nov 29 [Epub ahead of print].
5. Bilge AK, Ozben B, Demircan S, et al. Depression and anxiety status of patients with implantable cardioverter defibrillator and precipitating factors. Pacing Clin Electrophysiol 2006; 29: 619-26.
6. Anderson KP. Sudden cardiac death unresponsive to implantable defibrillator therapy: an urgent target for clinicians, industry and government. J Interv Card Electrophysiol 2005; 14: 71-8.
7. Szumowski L, Sanders P, Walczak F, et al. Mapping and ablation of polymorphic ventricular tachycardia after myocardial infarction. J Am Coll Cardiol 2004; 44: 1700-6.
8. Bansch D, Oyang F, Antz M, et al. Successful catheter ablation of electrical storm after myocardial infarction. Circulation 2003; 108: 3011-16.
9. O'Callaghan PA, Poloniecki J, Sosa-Suarez G, et al. Long-term clinical outcome of patients with prior myocardial infarction after palliative radiofrequency catheter ablation for frequent ventricular tachycardia. Am J Cardiol 2001; 87: 975-9.
10. Silva RM, Mont L, Nava S, et al. Radiofrequency catheter ablation for arrhythmic storm in patients with an implantable cardioverter defibrillator. Pacing Clin Electrophysiol 2004; 27: 971-5.
11. Schreieck J, Zrenner B, Deisenhofer I, et al. Rescue ablation of electrical storm in patients with ischemic cardiomyopathy: a potential guided ablation approach by modifying substrate of intractable, unmappable ventricular tachycardias. Heart Rhythm 2005; 2: 10-4.
12. Carbucicchio C, Santamaria M, Trevisi N, et al. Catheter ablation for the treatment of electrical storm in patients with implantable cardioverter- defibrillators: short- and long-term outcomes in a prospective single-center study. Circulation 2008; 117: 462-9.
13. Credner SC, Klingenheben T, Mauss O, et al. Electrical storm in patients with implantable cardioverter-defibrillators: incidence, management and prognostic implications. J Am Coll Cardiol 1998; 32: 1909-15.
14. Gatzoulis KA, Andronikopoulos GK, Apostolopoulos T, et al. Electrical storm is an independent predictor of adverse long-term outcome in the era of implantable defibrillator therapy. Europace 2005; 7: 184-92.
15. Sesselberg HW, Moss AJ, McNitt S, et al. (MADIT-II Research Group). Ventricular arrhythmia storms in postinfarction patients with implantable defibrillators for primary prevention indications: a MADIT-II substudy. Heart Rhythm 2007; 4: 1395-402.
16. Zipes DP, Camm AJ, Borggrefe M, et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. J Am Coll Cardiol 2006; 48: 247-346.
17. Josephson ME. Electrophysiology of ventricular tachycardia: an historical perspective. J Cardiovasc Electrophysiol 2003; 14: 1134-48.
18. Zeppenfeld K, Stevenson WG. Ablation of ventricular tachycardia in patients with structural heart disease. Pacing Clin Electrophysiol 2008; 31: 358-74.
19. Reddy VY, Reynolds MR, Neuzil P, et al. Prophylactic catheter ablation for the prevention of defibrillator therapy. N Engl J Med 2007; 357: 2657-65.